Search Tag: beta-blockers
2025 11 Sep
Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no therapy in patients with myocardial infarction (MI) and preserved or mildly reduced left ventricular ejection fraction (LVEF), according to results from the BETAMI and DANBLOCK trials. Findings are published...Read more
2025 31 Aug
Beta-blocker therapy did not reduce all-cause mortality, reinfarction, or heart failure (HF) admission in patients with myocardial infarction (MI) managed invasively who had left ventricular ejection fraction (LVEF) ≥40%, according to late-breaking results from the REBOOT trial presented in a Hot Line session at ESC Congress 2025 and published simultaneously...Read more
2024 13 Nov
Beta-blockers have long been a cornerstone in preventing further cardiovascular events following myocardial infarction (MI), based on early trials before modern treatments like percutaneous coronary intervention and antithrombotic agents became common. Beta-blockers work by reducing myocardial oxygen demand and preventing cardiac remodelling and arrhythmias....Read more
2023 30 Nov
An overview of vasopressor management, current evidence on its use, when to initiate vasopressor therapy for best possible patient outcome and a discussion regarding the use of landiolol in septic patients with persistent tachycardia. Optimising Vasopressin Initiation in Septic Shock Patients with septic shock, and especially...Read more
2023 30 Nov
An overview of vasopressor management, current evidence on its use, when to initiate vasopressor therapy for best possible patient outcome and a discussion regarding the use of landiolol in septic patients with persistent tachycardia. Optimising Vasopressin Initiation in Septic Shock Patients with septic shock, and especially...Read more
2022 08 Dec
A summary of a symposium organised by AOP Health with presentations from Ricard Ferrer, Vall d’Hebron University Hospital, Barcelona, Spain; Bruno Levy, Centre Hospitalier Universitaire de Nancy, CHU Nancy · Réanimation Médicale Brabois, France; and Michael Fries, St. Vincenz Krankenhaus Limburg, Department of Anesthesiology, Germany....Read more
2020 08 Oct
Almost half of the patients with sepsis suffer from myocardial depression and a reduced ejection fraction. Sepsis can also cause changes in circulating volume, vascular tone, and coronary blood flow, all of which affect heart function and heart rate. Serum catecholamine levels and direct measurements of renal sympathetic nerve activity have shown...Read more